Table 2.
Characteristics of the COVID-19 study population (No. = 162).
| Characteristics | COVID-19 patients | Missing data |
|---|---|---|
| Age, years (median, 95%CI) | 63 (52–72.5) | 0 |
| Sex Male | 108 (66.7%) | 0 |
| Ethnicity | 0 | |
| White Europeans | 145 9.5%) | |
| Hispanic | 12 7.4%) | |
| Asian | 4 (2.5%) | |
| African | 1 (0.6%) | |
| Co-morbidities | 0 | |
| Hypertension | 72 (44.4%) | |
| Coronary artery diseases (CAD) | 21 (13%) | |
| Diabetes | 40 (24.7%) | |
| Chronic obstructive pulmonary disease (COPD) | 6 (3.7%) | |
| Chronic Kidney Disease (CKD) | 24 (14.8%) | |
| Cancer | 17 (10.5%) | |
| Neurodegenerative disease (ND) | 5 (3.1%) | |
| Number of co-morbidities | 0 | |
| None | 69 (42.6%) | |
| 1 | 29 (17.9%) | |
| 2 | 42 (25.6%) | |
| 3 or more | 22 (13.6%) | |
| Body mass index (BMI) | 14 | |
| <25 | 40 (27%) | |
| 25-30 | 60 (40.5%) | |
| >30 | 48 (32.4%) | |
| Symptoms at disease onset | 5 | |
| General | ||
| Fever | 84.1% | |
| Headache | 24.2% | |
| fatigue/malaise | 56.7% | |
| myalgia/arthralgia | 33.1% | |
| Respiratory | ||
| Cough | 61.1% | |
| Dyspnea | 65.6% | |
| Sore throat | 17.8% | |
| Chest pain | 22.9% | |
| Gastrointestinal | ||
| Diarrhea | 28% | |
| Vomiting/nausea | 14% | |
| Abdominal pain | 8.9% | |
| Others | ||
| Conjunctivitis | 14% | |
| Hypo/anosmia | 35.7% | |
| Hypo/dysgeusia | 39.7% | |
| Skin rash | 6% | |
| Median days (95%CI) from symptoms onset: | 0 | |
| To hospital admission | 9 (5–12) | |
| To first blood sampling for Biobank | 11.5 (7–18) | |
| Median days of hospital stay of 134 hospitalized patients (95%CI) | 14 (7–24) | 0 |
| Median days from symptoms to negative RT-PCR swab (95%CI) | 40 (37–43) | 7 |
| Median follow-up days (95%CI) | 201 (196–205) | na |
na not applicable
If not otherwise defined, the number of patients for each listed characteristic is reported. The median BMI was 27.84 (IQR: 24.48-31.42). Missing data are indicated for each group of categories